Alan D. Frazier

This profile gathers the share dealings of Alan D. Frazier across 2 companies, led by Cadence Pharmaceuticals Inc and Alexza Pharmaceuticals Inc. The record holds 16 filings, for trades running from 13 March 2006 to 19 March 2014.

Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The record was last updated on 21 March 2014 with a transaction (€48.2M) in Cadence Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.